NYMOX PHARMACEUTICAL CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NYMXF and buy or sell other stocks, ETFs, and their options commission-free!About NYMXF
Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer.
CEOPaul Averback
CEOPaul Averback
Employees—
Employees—
HeadquartersNassau, New Providence
HeadquartersNassau, New Providence
Founded1995
Founded1995
Employees—
Employees—
NYMXF Key Statistics
Market cap18.91K
Market cap18.91K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume4.36K
Average volume4.36K
High today$0.0002
High today$0.0002
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume20.25K
Volume20.25K
52 Week high$0.1999
52 Week high$0.1999
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
NYMOX PHARMACEUTICAL CORP(NYMXF) stock is priced at $0.00, giving the company a market capitalization of 18.91K.
On 2026-09-08, NYMOX PHARMACEUTICAL CORP(NYMXF) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 20.25K, compared to an average daily volume of 4.36K.
Over the past 52 weeks, NYMOX PHARMACEUTICAL CORP(NYMXF) stock has traded between a high of $0.20 and a low of $0.00.
Over the past 52 weeks, NYMOX PHARMACEUTICAL CORP(NYMXF) stock has traded between a high of $0.20 and a low of $0.00.
People also own
Based on the portfolios of people who own NYMXF. This list is generated using Robinhood data, and it’s not a recommendation.